Thoroughbred Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
22,236
-100
-0.4% -$6.82K 0.08% 207
2026
Q1
$1.44M Buy
22,336
+629
+3% +$44.3K 0.09% 225
2025
Q4
$1.46M Buy
21,707
+717
+3% +$48.2K 0.09% 215
2025
Q3
$1.54M Sell
20,990
-150
-0.7% -$9.96K 0.1% 203
2025
Q2
$1.1M Buy
+21,140
New +$1.2M 0.08% 247

Other funds holding HALO

Thoroughbred Financial Services's HALO Position: Q2 2026 in Review

Thoroughbred Financial Services reduced its Halozyme (HALO) stake by 0.45% in Q2 2026, selling an estimated $6.82K and leaving 22,236 shares worth $1.74M. The position accounts for 0.08% of the portfolio, ranked #207.

Thoroughbred Financial Services first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Thoroughbred Financial Services held 22,236 shares of Halozyme worth $1.74M as of Q2 2026.
  • Thoroughbred Financial Services sold 100 Halozyme shares in Q2 2026, an estimated $6.82K.
  • Halozyme made up 0.08% of Thoroughbred Financial Services's portfolio in Q2 2026, its #207 holding.
  • Thoroughbred Financial Services first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.